FDA approves new Ebola test in remote areas

The US Food and Drug Administration (FDA) has approved the urgent use of a new test for Ebola virus by taking a blood sample from a finger, from a patient. reader allowing to obtain results outside the laboratory.

The new test provides test results in remote areas with limited laboratory resources, such as those in African countries affected by the Ebola outbreak, the Food and Drug Administration said in a press release.

"The Ebola outbreak proves with disgust that we are a global community in protecting public health. Infectious diseases do not recognize the state," said the Commissioner of Food and Disease. Drug Administration, Scott Gottlieb.

The US Food and Drug Administration warned that the results of the examination should not be the sole criterion used to determine the course of treatment of the patient, indicating that medical staff should think about the antecedents, signs and symptoms. patient's symptoms and at the risk of exposure.